News

Filter

Current filters:

None

8026 to 8035 of 96678 results

Access to low-price generics threatened by technologies due to be used in EU

30-04-2012

Producers of generic medicines are raising concerns on the huge cost implications of possible new anti-falsification…

EuropeGenericsRegulation

Two drugs better than one to treat youth with type 2 diabetes

30-04-2012

A combination of two diabetes drugs, metformin and rosiglitazone (the active ingredient of GlaxoSmithKline's…

AvandiaDiabetesmetforminPharmaceuticalResearchrosiglitazone

Haemonetics to buy Pall Corp blood collection and processing lines for $550 million; and Hemerus Medical

30-04-2012

USA-based Pall Corp (NYSE: PLL) has entered into an agreement to sell certain assets of its blood collection,…

HaemoneticsHemerus MedicalMergers & AcquisitionsPall CorpPharmaceutical

Biopharmaceuticals "no longer a growth market" in Germany

30-04-2012

After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPoliticsPricingRegulation

Merck & Co 1st-qtr earnings just beat expectations; wins Mylan patent dispute

30-04-2012

US drug giant Merck & Co sales that global sales in the first-quarter of 2012 increased 1% to $11.7 billion,…

FinancialLegalMerck & CoMylan LaboratoriesNorth AmericaPatentsPharmaceuticalVytorinZetia

US FDA clears new ED drug Stendra

30-04-2012

The US Food and Drug Administration late Friday gave its approval for drug developer Vivus (Nasdaq: VVUS)…

avanafilMen's HealthNorth AmericaPharmaceuticalRegulationReproductiveStendraVivus

Novo Nordisk starts year with 15% net profits hike

30-04-2012

Danish insulin giant Novo Nordisk (NOV: N) reported first-quarter 2012 results last Friday, with a 13%…

DegludecDiabetesFinancialNovo NordiskPharmaceuticalRyzodegTresiba

FDA stalls Amgen's Xgeva sBLA for prevention of bone metastases

30-04-2012

USA-based Amgen (Nasdaq: AMGN) revealed on Friday that the US Food and Drug Administration has issued…

AmgenBiotechnologyNorth AmericaOncologyRegulationXgeva

Jazz Pharma to acquire EUSA Pharma for up to $700 million

29-04-2012

US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) said last week that it has signed a definitive accord…

EUSA PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceutical

8026 to 8035 of 96678 results

Parexel

Parexel

Back to top